» Articles » PMID: 38076066

Willis Covered Stent Treatment for Internal Carotid Artery Pseudoaneurysm: A Meta-analysis of Efficacy and Safety

Overview
Journal Heliyon
Specialty Social Sciences
Date 2023 Dec 11
PMID 38076066
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Pseudoaneurysm (PSA) of internal carotid artery is a rare but severe cerebrovascular disease and difficult to repair surgically. A novel medical device called Willis covered stent (WCS) has been created especially for the treatment of complex cerebrovascular diseases. However, the efficacy and safety of WCS therapy for PSA are still debatable. Additional substantial proof is needed.

Methods: To find research pertaining to WCS treatment for PSA, a systematic review of literature was conducted in the Medline, Embase, Web of Science, CNKI, Wanfang, and CBM databases. The results comprising the data of intraoperative situation, postoperative situation, and follow-up were then included in a meta-analysis.

Results: The criteria were met by 11 noncomparative studies with 152 patients and 157 PSAs. Technical success rate was nearly 100 % (>0.999 (95 % confidence interval (CI), 0.958, 1.000)), complete occlusion rate was 97.8 % (95 % CI, 0.932, 1.000), and side branch occlusion rate was 0.5 % (95 % CI, 0.001, 0.045). The rates of acute in-stent thrombosis (<0.001 (95 % CI, 0.000, 0.013)) and hemorrhage (<0.001 (95 % CI, 0.000, 0.005)) were both less than 0.1 %. In postoperative situation, surgery-related mortality rate was less than 0.1 % (<0.001 (95 % CI, 0.000, 0.005)). The rates of recurrence (<0.001 (95 % CI, 0.000, 0.002)) and parent artery stenosis (<0.001 (95 % CI, 0.000, 0.008)) were both less than 0.1 %, while late in-stent stenosis occurred in 1.3 % (95 % CI, 0.000, 0.053) of patients. In the end, 98.5 % (95 % CI, 0.943, 1.000) of patients had a good outcome.

Conclusion: The application of WCS could be effective and safe for PSAs. The findings of this study could serve as a reference for upcoming clinical trials.

References
1.
Rubin R . New AHRQ Patient Safety Guidance. JAMA. 2020; 323(16):1542. DOI: 10.1001/jama.2020.5603. View

2.
Kan P, Duckworth E, Puri A, Velat G, Wakhloo A . Treatment failure of fetal posterior communicating artery aneurysms with the pipeline embolization device. J Neurointerv Surg. 2015; 8(9):945-8. DOI: 10.1136/neurintsurg-2015-011959. View

3.
Wang K, Peng X, Liu A, Zhang Y, Lv J, Xiang L . Covered Stenting Is an Effective Option for Traumatic Carotid Pseudoaneurysm with Promising Long-Term Outcome. J Korean Neurosurg Soc. 2020; 63(5):590-597. PMC: 7477158. DOI: 10.3340/jkns.2019.0202. View

4.
Li M, Li Y, Gao B, Fang C, Luo Q, Cheng Y . A new covered stent designed for intracranial vasculature: application in the management of pseudoaneurysms of the cranial internal carotid artery. AJNR Am J Neuroradiol. 2007; 28(8):1579-85. PMC: 8134415. DOI: 10.3174/ajnr.A0668. View

5.
Chen S, McCarthy D, Sheinberg D, Hanel R, Sur S, Jabbour P . Pipeline Embolization Device for the Treatment of Intracranial Pseudoaneurysms. World Neurosurg. 2019; 127:e86-e93. DOI: 10.1016/j.wneu.2019.02.135. View